;; 1. Based on: run56 ;; 2. Description: Final model ;; x1. Author: user ;; Including all data along with rich datset ;; 3. Label: ;; ;; 4. Structural model: ;; 2 CMT, IV administration ;; 5. Covariate model: ;;
WT on V1 (both), WT on CL (IP), CRCL on CL (both) & HLTH on V1 (IP) ;; 6. (5)) V1_RL = TVV1_RL*EXP(ETA(6)) V2_RL = TVV2_RL*EXP(ETA (7)) Q_RL = TVQ_RL*EXP(ETA (8)) IF(DRUG.EQ.1) THEN CL = CL_IP V1 = V1_IP V2 = V2_IP Q = Q_IP S1 = V1_IP ELSE CL = CL_RL V1 = V1_RL V2 = V2_RL Q = Q_RL S1 = V1_RL ENDIF ; $ERROR ;
DEL=0 IF (F.LE.0.0001) DEL=1 IPRED=F W1= 1 W2= F IRES= DV-IPRED IWRES=(1-DEL)*IRES/(W1+W2+DEL) ; X1=0 X2=0 ; IF (DRUG.EQ.1) X1=1 IF (DRUG.EQ.2) X2=1 RV_IP = X1*(F*(1+ERR(1)) + ERR(2)) RV_MK = X2*(F*(1+ERR(3)) + ERR(4)) Y = RV_IP + RV_MK ; ; $THETA (0,11.7) ; [TVCL_IP] (L/h) $THETA (0,14.5) ; [TVV1_IP] (L) $THETA (0,6.3) ; [TVV2_IP] (L) $THETA (0,11.1) ; [TVQ_IP] (L/h) $THETA (0,6.52) ; [TVCL_RL] (L/h) $THETA (0,11.1) ; [TVV1_RL] (L) $THETA (0,6.65) ; [TVV2_RL] (L) $THETA (0,10.3) ; [TVQ_RL] (L/h) $THETA (0,0.5, 2.00) ; CL_IPCRCL1 $THETA (0,1, 2.00) ; CL_IPWT1 https://mysite.mpf.exostar.com/sites/ID-VaccinesPublications/Gram Negative/IMIREL PopPK Manuscript/run60-mod.txt 3/3 $THETA (0,0.5, 2.00) ; CL_RLCRCL1 $THETA (-1,-0.001,5) ; V1_IPHLTH1 $THETA (0,1, 2.00) ; V1_IPWT1 $THETA (0,1, 2.00) ; V1_RLWT1 $OMEGA BLOCK(2) 0. 
